{"timestamp": 1771602872.6871371, "value": {"ticker": "TCRX", "company_name": "TScan Therapeutics, Inc.", "short_name": "TScan Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 57882952, "float_shares": 47120696, "shares_outstanding": 52471405, "short_ratio": 4.95, "short_percent_of_float": 0.055, "shares_short": 2566263, "shares_short_prior": 2077294, "insider_percent_held": 0.00228, "institution_percent_held": 0.65952003, "total_cash": 184452992, "total_debt": 95622000, "total_revenue": 8423000, "revenue_growth": 1.394, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": -1.48854, "operating_margins": -14.755871, "debt_to_equity": 66.394, "current_ratio": 6.442, "book_value": 2.538, "price_to_book": 0.40189123, "operating_cashflow": -130729000, "free_cashflow": -87761752, "price": 1.02, "52w_high": 2.57, "52w_low": 0.882, "avg_volume": 609155, "avg_volume_10d": 463730, "full_time_employees": 146, "audit_risk": 0, "overall_risk": 0}}